Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues
about
XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivationThe translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesisInvolvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis.Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?Hepatitis B virus infection and primary hepatocellular carcinoma.Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascadeThe woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks.Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis.Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma.Regulation of transforming growth factor-beta 1 expression by the hepatitis B virus (HBV) X transactivator. Role in HBV pathogenesis.Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.Frequent amplification of c-myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus.Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas.Detection and sequence analysis of hepatitis B virus integration in peripheral blood mononuclear cells.Integrated hepatitis B virus DNA preserves the binding sequence of transcription factor Yin and Yang 1 at the virus-cell junction.The binding site of transcription factor YY1 is required for intramolecular recombination between terminally repeated sequences of linear replicative hepatitis B virus DNA.The C-terminal region of the hepatitis B virus X protein is essential for its stability and function.Loss and acquisition of duck hepatitis B virus integrations in lineages of LMH-D2 chicken hepatoma cells.A transcription initiation site for the hepatitis B virus X gene is directed by the promoter-binding protein.Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C.Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA.Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2.C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.The role of hepatitis B virus in development of primary hepatocellular carcinoma: Part II.Pathogenesis of hepatocellular carcinoma: a review from the viewpoint of molecular analysis.The molecular pathogenesis of hepatocellular carcinoma.Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis.Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer.Characteristics of human hepatocellular carcinoma cell lines (Hep-KANO) derived from a non-hepatitic, non-cirrhotic hepatitis B virus carrier.Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway.State of HBV DNA in HBsAg-negative, anti-HCV-positive hepatocellular carcinoma: existence of HBV DNA possibly as nonintegrated form with analysis by Alu-HBV DNA PCR and conventional HBV PCR.Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy.Molecular, immunological and clinical properties of mutated hepatitis B viruses.Survey of hepatitis B virus co-infection in hepatitis C virus-infected patients suffering from chronic hepatitis and hepatocellular carcinoma in Japan.Pathogenesis of hepatitis B virus-associated hepatocellular carcinoma.Post-transcriptional control of the level of mRNA by hepatitis B virus X gene in the transient expression system using human hepatic cells.X protein of hepatitis B virus resembles a serine protease inhibitor.
P2860
Q24544043-6B800C3A-ECB5-4939-818F-37766F226916Q28141874-D6D47482-6455-4CB2-9BFE-3AD1CB4A3E3DQ33801352-0F1480CE-2728-4EED-A3AF-30578A145E5BQ33883921-09D8946B-58A0-4265-B981-FAB3A1126972Q34988085-FAEA3F79-466B-45DC-8B80-AF8A862C36AFQ35231554-FC3C497C-B709-4963-800A-5817D991B6DDQ35850088-5C19FE1E-CE44-4CC5-8379-48D05CF2B910Q36642780-1A513C5A-2377-4535-A42A-2280AA3505B3Q36830710-A0113754-77BC-4E2C-A090-2DFF12669EAAQ37288584-4529019C-DB71-48CB-AB01-6F373DF1A481Q37350292-3DE28529-FEEA-4B5B-A9E8-949A772B8B87Q37388018-FA755A6A-CAB0-4792-935D-871EE8BE80F6Q37594965-DD42494E-5E6C-477E-9E84-4C9430456877Q37599222-3208BE2E-5AC8-43D7-A0DA-067693F0FD87Q38216013-75F76E3F-0C91-40B8-A112-E0FB50FC3755Q39486033-896F3F17-9965-4AAE-9097-4708B73540D0Q39549331-AC69A357-F12D-4E82-9FAF-91AAB1A3D3ADQ39591418-3E600B27-8E15-4118-B2C2-2BAF505E16A5Q39593278-E0C2EB76-1E3E-416C-A9DA-8C49B731227BQ39640953-5294F6FE-B72B-4A04-9801-57FF11B5A0F7Q39873876-1B2C0044-B408-4797-9283-A302CD0664FCQ40044758-F5CBB29D-E3FA-4C50-810F-275710A714E4Q40064034-7FD96AF2-6EEA-45A9-9EDD-8302A74E3DC8Q40106284-271A64C5-3937-4806-B282-046CB3A6E69FQ40541428-E6491BC9-9DB5-4F05-848E-5B6CFDA94319Q40744258-C17F0F78-25D1-4F41-B7B8-D4B8EB48E824Q40851672-67A7A569-4109-4B85-9487-C3F77D4D519CQ41051463-BCA73F33-FF2A-4F8A-B949-346732839068Q41098848-EA6036BB-E44E-42CD-B83E-1B9D668F2CE0Q41167238-058C0540-7CAF-4038-AA18-7F2D94E50270Q42440320-37472525-E04D-423D-9EE2-6792F9F2B3B8Q42806130-08F95004-04B9-4310-94D2-C4C63DE38FACQ43565298-330469A9-9E5E-4740-90A7-B0F3A6065814Q43795086-EFDDD13A-258B-40E2-A2A9-2B6E59F8B952Q43892507-1A46BE96-5522-48B9-BCA8-BBD6F225C73EQ43988430-7C94C603-EB06-43AD-B88A-182A2FE21B4AQ44619727-A746D5FE-6749-4CA5-96EC-F6ADBF9BBAEEQ45400037-8914F78E-C8B9-4058-A0C3-4B3C8504FD47Q45753669-2476F3B0-9650-4E23-9722-F6D871880CACQ45852144-7E4C4A3A-2138-475A-8E46-5E8F589352F3
P2860
Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Trans-activation function of a ...... A in chronic hepatitis tissues
@ast
Trans-activation function of a ...... A in chronic hepatitis tissues
@en
type
label
Trans-activation function of a ...... A in chronic hepatitis tissues
@ast
Trans-activation function of a ...... A in chronic hepatitis tissues
@en
prefLabel
Trans-activation function of a ...... A in chronic hepatitis tissues
@ast
Trans-activation function of a ...... A in chronic hepatitis tissues
@en
P2860
P356
P1476
Trans-activation function of a ...... A in chronic hepatitis tissues
@en
P2093
P2860
P304
P356
10.1073/PNAS.87.15.5628
P407
P577
1990-08-01T00:00:00Z